🇺🇸 FDA
Patent

US 8592577

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8592577 (Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P35/00, A61P43/00